PDCD4_HUMAN - dbPTM
PDCD4_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID PDCD4_HUMAN
UniProt AC Q53EL6
Protein Name Programmed cell death protein 4
Gene Name PDCD4
Organism Homo sapiens (Human).
Sequence Length 469
Subcellular Localization Nucleus . Cytoplasm . Shuttles between the nucleus and cytoplasm (By similarity). Predominantly nuclear under normal growth conditions, and when phosphorylated at Ser-457 (PubMed:16357133).
Protein Description Inhibits translation initiation and cap-dependent translation. May excert its function by hindering the interaction between EIF4A1 and EIF4G. Inhibits the helicase activity of EIF4A. Modulates the activation of JUN kinase. Down-regulates the expression of MAP4K1, thus inhibiting events important in driving invasion, namely, MAPK85 activation and consequent JUN-dependent transcription. May play a role in apoptosis. Tumor suppressor. Inhibits tumor promoter-induced neoplastic transformation. Binds RNA (By similarity)..
Protein Sequence MDVENEQILNVNPADPDNLSDSLFSGDEENAGTEEIKNEINGNWISASSINEARINAKAKRRLRKNSSRDSGRGDSVSDSGSDALRSGLTVPTSPKGRLLDRRSRSGKGRGLPKKGGAGGKGVWGTPGQVYDVEEVDVKDPNYDDDQENCVYETVVLPLDERAFEKTLTPIIQEYFEHGDTNEVAEMLRDLNLGEMKSGVPVLAVSLALEGKASHREMTSKLLSDLCGTVMSTTDVEKSFDKLLKDLPELALDTPRAPQLVGQFIARAVGDGILCNTYIDSYKGTVDCVQARAALDKATVLLSMSKGGKRKDSVWGSGGGQQSVNHLVKEIDMLLKEYLLSGDISEAEHCLKELEVPHFHHELVYEAIIMVLESTGESTFKMILDLLKSLWKSSTITVDQMKRGYERIYNEIPDINLDVPHSYSVLERFVEECFQAGIISKQLRDLCPSRGRKRFVSEGDGGRLKPESY
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
1Acetylation-------MDVENEQI
-------CCCCCCCC
13.5420068231
2 (in isoform 2)Phosphorylation-57.3428348404
4 (in isoform 2)Phosphorylation-51.2728348404
14PhosphorylationQILNVNPADPDNLSD
CCCCCCCCCCCCCCC
35.4527251275
14 (in isoform 2)Phosphorylation-35.4528348404
20PhosphorylationPADPDNLSDSLFSGD
CCCCCCCCCCCCCCC
31.2620363803
22PhosphorylationDPDNLSDSLFSGDEE
CCCCCCCCCCCCCCC
28.1220068231
22 (in isoform 2)Phosphorylation-28.1227174698
25PhosphorylationNLSDSLFSGDEENAG
CCCCCCCCCCCCCCC
51.1020363803
46PhosphorylationEINGNWISASSINEA
HHCCCEECHHHHCHH
17.4525159151
48PhosphorylationNGNWISASSINEARI
CCCEECHHHHCHHHH
25.5920068231
49PhosphorylationGNWISASSINEARIN
CCEECHHHHCHHHHH
29.2020068231
58UbiquitinationNEARINAKAKRRLRK
CHHHHHHHHHHHHHH
50.37-
60UbiquitinationARINAKAKRRLRKNS
HHHHHHHHHHHHHCC
37.03-
67PhosphorylationKRRLRKNSSRDSGRG
HHHHHHCCCCCCCCC
29.7723401153
68PhosphorylationRRLRKNSSRDSGRGD
HHHHHCCCCCCCCCC
49.8827273156
71PhosphorylationRKNSSRDSGRGDSVS
HHCCCCCCCCCCCCC
29.3125159151
73MethylationNSSRDSGRGDSVSDS
CCCCCCCCCCCCCCC
50.09115386825
76PhosphorylationRDSGRGDSVSDSGSD
CCCCCCCCCCCCCHH
26.7529255136
78PhosphorylationSGRGDSVSDSGSDAL
CCCCCCCCCCCHHHH
29.9729255136
80PhosphorylationRGDSVSDSGSDALRS
CCCCCCCCCHHHHHC
32.4629255136
82PhosphorylationDSVSDSGSDALRSGL
CCCCCCCHHHHHCCC
24.5427273156
87PhosphorylationSGSDALRSGLTVPTS
CCHHHHHCCCCCCCC
38.7223927012
90PhosphorylationDALRSGLTVPTSPKG
HHHHCCCCCCCCCCC
28.1523927012
93PhosphorylationRSGLTVPTSPKGRLL
HCCCCCCCCCCCCCC
54.0129255136
94PhosphorylationSGLTVPTSPKGRLLD
CCCCCCCCCCCCCCC
20.6719664994
96UbiquitinationLTVPTSPKGRLLDRR
CCCCCCCCCCCCCCC
57.33-
121UbiquitinationKKGGAGGKGVWGTPG
CCCCCCCCCCCCCCC
49.74-
126PhosphorylationGGKGVWGTPGQVYDV
CCCCCCCCCCCEEEE
14.4521815630
131PhosphorylationWGTPGQVYDVEEVDV
CCCCCCEEEEEEECC
13.3422210691
143PhosphorylationVDVKDPNYDDDQENC
ECCCCCCCCCCCCCC
26.5722817900
152PhosphorylationDDQENCVYETVVLPL
CCCCCCEEEEEEEEC
14.2125159151
166UbiquitinationLDERAFEKTLTPIIQ
CCHHHHHHHCHHHHH
42.2421906983
175PhosphorylationLTPIIQEYFEHGDTN
CHHHHHHHHHCCCHH
9.6327642862
197UbiquitinationDLNLGEMKSGVPVLA
HCCCCCCCCCCCEEE
39.49-
212UbiquitinationVSLALEGKASHREMT
HHHHHCCCHHHHHHH
37.02-
224PhosphorylationEMTSKLLSDLCGTVM
HHHHHHHHHHHCCHH
38.6929449344
229PhosphorylationLLSDLCGTVMSTTDV
HHHHHHCCHHCCHHH
16.4329449344
231UbiquitinationSDLCGTVMSTTDVEK
HHHHCCHHCCHHHHH
2.7121890473
232PhosphorylationDLCGTVMSTTDVEKS
HHHCCHHCCHHHHHH
24.6629449344
233PhosphorylationLCGTVMSTTDVEKSF
HHCCHHCCHHHHHHH
14.6629449344
234PhosphorylationCGTVMSTTDVEKSFD
HCCHHCCHHHHHHHH
30.6429449344
238UbiquitinationMSTTDVEKSFDKLLK
HCCHHHHHHHHHHHH
57.16-
239PhosphorylationSTTDVEKSFDKLLKD
CCHHHHHHHHHHHHH
25.7729449344
242UbiquitinationDVEKSFDKLLKDLPE
HHHHHHHHHHHHCHH
54.4221890473
242UbiquitinationDVEKSFDKLLKDLPE
HHHHHHHHHHHHCHH
54.4221890473
245UbiquitinationKSFDKLLKDLPELAL
HHHHHHHHHCHHHHC
68.6021906983
254PhosphorylationLPELALDTPRAPQLV
CHHHHCCCCCHHHHH
18.61-
267MethylationLVGQFIARAVGDGIL
HHHHHHHHHHCCCEE
25.62115486721
283UbiquitinationNTYIDSYKGTVDCVQ
CEEECCCCCCHHHHH
52.652190698
297AcetylationQARAALDKATVLLSM
HHHHHHHHHHHEEEC
46.9725953088
297UbiquitinationQARAALDKATVLLSM
HHHHHHHHHHHEEEC
46.97-
299PhosphorylationRAALDKATVLLSMSK
HHHHHHHHHEEECCC
19.8920068231
303PhosphorylationDKATVLLSMSKGGKR
HHHHHEEECCCCCCC
19.4920068231
305PhosphorylationATVLLSMSKGGKRKD
HHHEEECCCCCCCCC
25.4427251275
306AcetylationTVLLSMSKGGKRKDS
HHEEECCCCCCCCCC
64.1425953088
306UbiquitinationTVLLSMSKGGKRKDS
HHEEECCCCCCCCCC
64.14-
311UbiquitinationMSKGGKRKDSVWGSG
CCCCCCCCCCCCCCC
58.82-
313PhosphorylationKGGKRKDSVWGSGGG
CCCCCCCCCCCCCCH
23.8620044836
317PhosphorylationRKDSVWGSGGGQQSV
CCCCCCCCCCHHHHH
20.6723401153
323PhosphorylationGSGGGQQSVNHLVKE
CCCCHHHHHHHHHHH
19.5923401153
333SulfoxidationHLVKEIDMLLKEYLL
HHHHHHHHHHHHHHH
6.0821406390
345PhosphorylationYLLSGDISEAEHCLK
HHHHCCHHHHHHHHH
35.1825159151
392UbiquitinationDLLKSLWKSSTITVD
HHHHHHHHCCCCCHH
39.56-
393PhosphorylationLLKSLWKSSTITVDQ
HHHHHHHCCCCCHHH
22.5720068231
394PhosphorylationLKSLWKSSTITVDQM
HHHHHHCCCCCHHHH
21.8020068231
395PhosphorylationKSLWKSSTITVDQMK
HHHHHCCCCCHHHHH
27.9720068231
397PhosphorylationLWKSSTITVDQMKRG
HHHCCCCCHHHHHHH
20.3720068231
402UbiquitinationTITVDQMKRGYERIY
CCCHHHHHHHHHHHH
36.72-
4022-HydroxyisobutyrylationTITVDQMKRGYERIY
CCCHHHHHHHHHHHH
36.72-
405PhosphorylationVDQMKRGYERIYNEI
HHHHHHHHHHHHHHC
13.1822817900
440PhosphorylationCFQAGIISKQLRDLC
HHHHCHHHHHHHHHC
16.6624719451
457PhosphorylationRGRKRFVSEGDGGRL
CCCCCCCCCCCCCCC
32.9029255136
465SumoylationEGDGGRLKPESY---
CCCCCCCCCCCC---
45.43-
465SumoylationEGDGGRLKPESY---
CCCCCCCCCCCC---
45.43-
468PhosphorylationGGRLKPESY------
CCCCCCCCC------
44.6721815630
469PhosphorylationGRLKPESY-------
CCCCCCCC-------
22.4023186163

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources
67SPhosphorylationKinaseAKT1P31749
PSP
67SPhosphorylationKinaseP70S6KP23443
PSP
67SPhosphorylationKinaseAKT-FAMILY-GPS
67SPhosphorylationKinasePKB_GROUP-PhosphoELM
76SPhosphorylationKinaseRPS6KA1Q15418
GPS
457SPhosphorylationKinaseAKT1P31749
PSP
457SPhosphorylationKinaseRPS6KA1Q15418
GPS
457SPhosphorylationKinaseP70S6KP23443
PSP
457SPhosphorylationKinaseAKT-FAMILY-GPS
457SPhosphorylationKinasePKB_GROUP-PhosphoELM
-KUbiquitinationE3 ubiquitin ligaseBTRCQ9Y297
PMID:17053147
-KUbiquitinationE3 ubiquitin ligaseFBXW11Q9UKB1
PMID:24658274
-KUbiquitinationE3 ubiquitin ligaseSKP2Q13309
PMID:30760284
-KUbiquitinationE3 ubiquitin ligaseDTLQ9NZJ0
PMID:31409387

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference
67SPhosphorylation

16357133

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of PDCD4_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
RL5_HUMANRPL5physical
12054647
RS13_HUMANRPS13physical
12054647
IF4G1_HUMANEIF4G1physical
12054647
FBW1A_HUMANBTRCphysical
18296647
FBW1A_HUMANBTRCphysical
17053147
FBW1A_HUMANBTRCphysical
23056346
DAXX_HUMANDAXXphysical
23536002
ARC1B_HUMANARPC1Bphysical
22863883
BTF3_HUMANBTF3physical
22863883
PAIP1_HUMANPAIP1physical
22863883
TPD52_HUMANTPD52physical
22863883
UFD1_HUMANUFD1Lphysical
22863883
IF4A2_HUMANEIF4A2physical
26344197
IF6_HUMANEIF6physical
26344197
ERF1_HUMANETF1physical
26344197
CNDD3_HUMANNCAPD3physical
26344197
PCF11_HUMANPCF11physical
26344197
PRS4_HUMANPSMC1physical
26344197
SMD1_HUMANSNRPD1physical
26344197
UBE2S_HUMANUBE2Sphysical
25928036
IBTK_HUMANIBTKphysical
25882842

Drug and Disease Associations
Kegg Disease
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of PDCD4_HUMAN

loading...

Related Literatures of Post-Translational Modification
Phosphorylation
ReferencePubMed
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions.";
Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.;
Sci. Signal. 2:RA46-RA46(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-94, AND MASSSPECTROMETRY.
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach.";
Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.;
Anal. Chem. 81:4493-4501(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-78 AND SER-94, AND MASSSPECTROMETRY.
"A quantitative atlas of mitotic phosphorylation.";
Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-76; SER-78; SER-80;SER-94 AND SER-457, AND MASS SPECTROMETRY.
"Automated phosphoproteome analysis for cultured cancer cells by two-dimensional nanoLC-MS using a calcined titania/C18 biphasic column.";
Imami K., Sugiyama N., Kyono Y., Tomita M., Ishihama Y.;
Anal. Sci. 24:161-166(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-93; SER-94 AND SER-457,AND MASS SPECTROMETRY.
"Evaluation of the low-specificity protease elastase for large-scalephosphoproteome analysis.";
Wang B., Malik R., Nigg E.A., Korner R.;
Anal. Chem. 80:9526-9533(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-76, AND MASSSPECTROMETRY.
"Global proteomic profiling of phosphopeptides using electron transferdissociation tandem mass spectrometry.";
Molina H., Horn D.M., Tang N., Mathivanan S., Pandey A.;
Proc. Natl. Acad. Sci. U.S.A. 104:2199-2204(2007).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-457, AND MASSSPECTROMETRY.
"S6K1- and betaTRCP-mediated degradation of PDCD4 promotes proteintranslation and cell growth.";
Dorrello N.V., Peschiaroli A., Guardavaccaro D., Colburn N.H.,Sherman N.E., Pagano M.;
Science 314:467-471(2006).
Cited for: FUNCTION, PHOSPHORYLATION AT SER-67 BY RPS6KB1, PHOSPHODEGRON MOTIF,INTERACTION WITH BTRC AND FBXW11, UBIQUITINATION, MASS SPECTROMETRY,AND MUTAGENESIS OF SER-67; SER-71 AND SER-76.
"A probability-based approach for high-throughput proteinphosphorylation analysis and site localization.";
Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.;
Nat. Biotechnol. 24:1285-1292(2006).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-93 AND SER-457, AND MASSSPECTROMETRY.
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks.";
Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.;
Cell 127:635-648(2006).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-76 AND SER-457, AND MASSSPECTROMETRY.
"Akt phosphorylates and regulates Pdcd4 tumor suppressor protein.";
Palamarchuk A., Efanov A., Maximov V., Aqeilan R.I., Croce C.M.,Pekarsky Y.;
Cancer Res. 65:11282-11286(2005).
Cited for: PHOSPHORYLATION AT SER-67 AND SER-457 BY PKB, FUNCTION, MUTAGENESIS OFSER-67 AND SER-457, AND SUBCELLULAR LOCATION.
"Immunoaffinity profiling of tyrosine phosphorylation in cancercells.";
Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J., Zhang H.,Zha X.-M., Polakiewicz R.D., Comb M.J.;
Nat. Biotechnol. 23:94-101(2005).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-152, AND MASSSPECTROMETRY.

TOP